Pathogenesis of Burkholderia pseudomaliei and Burkholderia mallei

Military Medicine

Volumn 174, Issue 6, 2009, Pages 647-651

  Larsen, Joseph C ^a   Johnson, Nathan H ^a  

^a DEFENSE THREAT REDUCTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN;

ANIMAL; BACTERIAL GENOME; BACTERIAL MEMBRANE; BIOLOGICAL WARFARE; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; DISEASE TRANSMISSION; GENETICS; GLANDERS; HORSE; HUMAN; MELIOIDOSIS; MICROBIOLOGY; PATHOGENICITY; QUORUM SENSING; REVIEW; SECRETION; VIRULENCE;

ANIMALS; BACTERIAL CAPSULES; BACTERIAL PROTEINS; BIOTERRORISM; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; EQUIDAE; GENOME, BACTERIAL; GLANDERS; HUMANS; MELIOIDOSIS; QUORUM SENSING; VIRULENCE;

EID: 77949368955     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED-D-03-0808     Document Type: Article

References (42)

1. White NJ:Meliodosis. Lancet 2003; 361: 1715-22.
2. White NJ, Dance DAB, Chaowagul W, Wattanagoon Y, Wuthiekanun V, Pitakawatchara N: Halving the mortality of severe melioidosis by ceftazadime. Lancet 1989; 65: 4022-9.
3. Currie BJ, Fisher DA, Howard DM, et al: Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin Infect Dis 2000; 31: 981-6.
4. Whitlock GC, Lukaszewski RA, Judy BM, Paessler S, Torres AG, Estes DM: Host immunity in the protective response to vaccination with heat-killed Burkholderia mallei. BMC Immunol 2008; 9: 55.
5. Jones SM, Ellis JF, Russell P. Griffin KF, Oyston PC: Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide, or proteins. J Med Microbiol 2002; 51: 55-62.
6. Currie BJ: Burkholderia pseudomallei and Burkholderia mallei: melioidosis and glanders. In: Mandell, Douglass. and Bennett's Principles and Practices of Infectious Disease, Ed 6. Edited by Mandell GL, Bennett JE, Dolin R. Philedelphia, PA, Elsevier, 2005.
7. Gregory BC, Waag DM: Glanders, Chapter 6. In: Medical Aspects of Biological Warfare. Washington, DC, Borden Institute, Walter Reed Army Medical Center, 2007.
8. Martin JW, Christopher GW, Eitzen EM Jr: History of biological weapons: from poisoned darts to intentional epidemics, Chapter 1. In: Medical Aspects of Biological Warfare. Washington, DC, Borden Institute, Walter Reed Army Medical Center, 2007.
9. Riedel S: Biological warfare and bioterrorism: a historical review. Proc (Bayl Univ Med Cent) 2004; 17: 400-06.
10. Wheelis M: First shots tired in biological warfare. Nature 1998; 395: 213.
11. Woods JB (editor) : United States Army Medical Research Institute of Infectious Disease (USAMRIID) Medical Management of Biological Casualties-Bluebook, Ed 6. 2005.
12. Vietri NJ, Deshazer D: Melioidosis, Chapter 7. In: Medical Aspects of Biological Warfare. Washington, DC, Borden Institute, Walter Reed Army Medical Center, 2007.
13. Chan YY, Tan TMC, Ong YM, Chua KL: BpeAB-OprB, a multidrug efflux pump in Burkholderia pseudomallei. Antimicrob Agents Chemother 2004; 48: 1128-35.
14. Moore RA, DeShazer D, Reckseidler S, Weissman A, Woods DE: Effluxmediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob Agents Chemother 1999; 43: 465-70.
15. Holden MT, Titball RW, Peacock SJ, et al: Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc Natl Acad Sci USA 2004; 101: 14240-5.
16. Nierman WC, DeShazer D, Kim HS, et al: Structural flexibility in the Burkholderia mallei genome. Proc Natl Acad Sci USA 2004; 101: 14246-51.
17. Moore RA, Reckseidler-Zenleno S, Kim H, et al: Contribution of gene loss to the pathogenic evolution of Burkholderia pseudomallei and Burkholderia mallei. Infect Immun 2004; 72: 4172-87.
18. Maurelli AT: Black holes, antivirulence genes, and gene inactivation in the evolution of bacterial pathogens. FEMS Microbiol Lett 2007; 267: 1-8.
19. Pilatz S, Breitbach K, Hein N, et al: Identification of Burkholderia pseudomallei genes required for the intracellular life cycle and in vivo virulence. Infect Immun 2006; 74: 6576-86.
20. Cucci J, Easton A, Chu KK, et al: Development of signature-tagged mutagenesis in Burkholderia pseudomallei to identify genes important in survival and pathogenesis. Infect Immun 2007; 75: 1186-95.
21. Schell MA, Lipscomb L, DeShazer D: Comparative genomics and an insect model rapidly identify novel virulence genes of Burkholderia mallei. J Bacteriol 2008; 190: 2306-13.
22. Tuanyok A, Tom M, Dunbar J, Woods DE; Genome-wide expression analysis of Burkholderia pseudomallei infection in a hamster model of acute melioidosis. Infect Immun 2006; 74: 5465-76.
23. Reckseidler SL, DeShazer D, Sokol PA, Woods DE: Detection of bacterial virulence genes by subtraetive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant. Infect Immun 2001; 69: 34-44.
24. DeShazer D, Waag DM, Fritz DE, Woods DE: Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant. Microb Pathog 2001; 30: 253-69.
25. Reckseidler-Zenteno SL, DeVinney R, Woods DE: The capsular polysaccharide of Burkholderia pseudomallei contributes to survival in serum by reducing complement factor C3b deposition. Infect Immun 2005; 73: 1106-15.
26. Ulrich RL, DeShazer D: Type III secretion: a virulence factor delivery system essential for the pathogenicity of Burkholderia mallei. Infect Immun 2004; 72: 1150-4.
27. Stevens MP, Wood MW, Taylor LA, et al; An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behavior of the pathogen. Mol Microbiol 2002; 46: 649-59.
28. Ribot WJ, Ulrich RL: The animal pathogen-like type III secretion system Is required for the intracellular survival of Burkholderia mallei within J 774.2 macrophages. Infect Immun 2006; 74: 4349-53.
29. Zhou DL, Chen LM, Hernandez L, Shears SB, Galán JE: A Salmonella inositol polyphosphate acts in conjunction with other bacterial effectors to promote host cell actin cytoskeletal rearrangements and bacterial internalization. Mol Microbiol 2001; 39: 248-59.
30. Stevens MP, Friebel A, Taylor LA, et al: A Burkholderia pseudomallei type III secreted protein, BopE, facilitates bacterial invasion of epithelial cells and exhibits guanine nucleotide exchange factor activity. J Bacteriol 2003; 185: 4992-6.
31. Stevens MP, Haque A, Atkins T, et al: Attenuated virulence and protective efficacy of Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis. Microbiology 2004; 150: 2669-76.
32. Collazo CM, Galán JE: The invasion-associated type III system of Salmonella typhimurium directs the translocation of Sip proteins into the host cell. Mol Microbiol 1997; 24: 747-56.
33. Frischknecht F, Way M: Surfing pathogens and the lessons learned for actin polymerization. Trends Cell Biol 2001; 11: 30-8.
34. Henderson IR, Navarro-Garcia F, Desvaux M, Fernandez RC, Ala' Aldeen D: Type V protein secretion pathway: the autotransporter story. Microbiol Mol Biol Rev 2004; 68: 692-744.
35. Stevens MP, Stevens JM, Jeng RE, et al: Identification of a bacterial factor required for actin-based motility of Burkholderia pseduomallei. Mol Microbiol 2005; 56: 40-53.
36. Higgs HN, Pollard TN: Regulation of actin polymerization by the Arp2/3 complex and WASp/Scar proteins. J Biol Chem 1999; 274: 32531-4.
37. Breitbach K, Rottner K, Klocke S, et al: Actin-based motility of Burkholderia pseudomallei involves the Arp 2/3 complex, but not N-WASP and Ena/VASP protiens. Cell Microbiol 2003; 5: 385-93.
38. Schell MA, Ulrich RL, Ribot WJ, et al: Type VI secretion is a major virulence determinant in Burkholderia mallei. Mol Microbiol 2007; 64: 1466-85.
39. Mougous JD, Cuff ME, Raunser S, et al: A virulence locus of Pseudomonas aeruginosa encodes a protein secretion apparatus. Science 2006; 312: 1526-30.
40. Pukatzi S, Ma AT, Sturtevant D: Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system, 2006; 103: 1528-33.
41. Ulrich RL, DeShazer D, Hines HB, Jeddeloh JA: Quorum sensing: a transcriptional regulatory system involved in the pathogenicity of Burkholderia mallei. Infect Immun 2004; 72: 6589-96.
42. Ulrich RL, DeShazer D. Brueggemann EE, Hines HB, Oyston PC, Jeddeloh J A: Role of quorum sensing in the pathogenicity of Burkholderia pseudomallei. J Med Microbiol 2004; 53: 1053-64.